ARCHIVES

BMS Control Of Billion-Dollar Taxol Market Facing Court Challeges By Competitors

This article is from The Cancer Letter archive.

Vol. 24 No. 21 | May 29, 1998

Download PDF Visit The Full Archive

Related Articles

Orlando Hospital Severs MD Anderson Ties, Forming Center with University of Florida

January 10, 2014

Avastin Improves PFS In Advanced Breast Cancer

April 29, 2005

SBRT Delivers Higher Overall Survival Rates Compared to Conventional Radiation Therapy

November 30, 2012

AVEO’s Tivozanib Sunk by Fundamental Flaw: Higher Overall Survival in the Control Arm

May 8, 2013

DCCP Payback System Saving $1 Million Year

December 3, 1982

Roche Reports New Avastin Results As FDA Mulls Breast Cancer Indication.

February 15, 2008